Efficacy of purified Vi polysaccharide typhoid vaccine.

J Vet Sci

Department of Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University, Suwon 441-744, Korea.

Published: June 2002

This experiment was conducted to assess the efficacy of typhoid vaccine newly produced by purifying Vi antigen of Salmonella typhi. With Karber method, LD50 of challenging organism (S. typhi ty2) was determined as 6.31 CFU/mouse, and then the organism was used for the study. With Probits method, ED50 of the vaccine was determined as 0.016 microg / 0.5 ml / mouse. The ELISA titer (0.5097+/-0.0606) was 4 times in the group treated with high dose (0.25 microg/0.5ml) as in control (0.1113+/-0.0110). Six major protein bands of 66, 55, 35, 33, 18, and 9 kd were detected in Western blot analysis with serum of a vaccine treated mouse, whereas only one weak band of about 35 kd was detected with serum of a control mouse. We concluded that typhoid vaccine produced by purifying Vi antigen of S. typhi very effectively prevent S. typhi infection in mice.

Download full-text PDF

Source

Publication Analysis

Top Keywords

typhoid vaccine
12
produced purifying
8
purifying antigen
8
vaccine
5
efficacy purified
4
purified polysaccharide
4
polysaccharide typhoid
4
vaccine experiment
4
experiment conducted
4
conducted assess
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!